Spanish Bioinformatics Firm Era7 Closes Capital Cell Campaign With Nearly €600,000 in Funds

Era7 Bioinformatics, a Spanish company that focuses on the revolution of the Microbiome and providing new solutions to address the problem of antibiotic resistance, announced this week it closed its Capital Cell campaign, which raised nearly €600,000 in funding.

era7-bioinformaticsAs previously reported, Era7 Bioinformatics was founded in 2005 in Granada by Dr. Eduardo Pareja and Dr. Raquel Tobes. The company uses its algorithms and cloud software to analyze billions of bacterial DNA sequences to extract from bacterial genomic and metagenomic big data findings and discoveries relevant for many fields such as Medicine and Human Health, Agriculture, Biotechnology, Biofuels and the Environment. It was revealed:

“We are assisting to a new revolution of the genomics: the Microbiome revolution. The Microbiome is the set of bacteria that live in an organism, in an environmental niche (a lake, a beach, a crop), in a place (your home, a hospital, your mobile phone). To know the Microbiome is very important for health, on one hand for fighting against pathogen bacteria and on the other hand to promote  the beneficial bacteria that maintain a healthy balance in our tissues.”

Following the closing of the company’s campaign, Era7 Bioinformatics CEO, Dr. Pareja, shared:

era7-bioinformatics“Today, we have a special milestone in our company which will drive us to expand our presence in the USA market. Our great team has been doing a lot of high quality R&D activities during the last years. At this stage, what we want is to increase sales based on all this value. This Expansion Plan will be funded with this campaign and allow us to get more customers for our new services of Microbiome analysis, Bacterial Genomics and Immunogenomics.”

Pareja then added:

“In addition, it has been a real pleasure to see how our collaborators, clients and providers have trusted on us investing in our company. We are very proud of it, since the people that better knows Era7 Bioinformatics have invested in the company.”


Have a crowdfunding offering you'd like to share? Submit an offering for consideration using our Submit a Tip form and we may share it on our site!



Sponsored Links by DQ Promote

 

 

Disclosure Quest

Reg A - Form 1-A Filings Beta

Beta. Initial Form 1-A only. Target raise is the stated Amount to be Raised, totaled. Compared with the same dates one year earlier.

YTD: Jan 1, 2026 - Oct 21, 2026 vs Jan 1, 2025 - Oct 21, 2025

Share this graph
Number of Filings130Prior 125 +4.0%
Target Raise, Total$3.37BPrior $3.54B -4.7%
This YTDYear priorChange
Filings 130 125 +4.0%
Target raise $3.37B $3.54B -4.7%

Sponsored by the Crowded Media Group the leading digital news service covering the global Fintech Industry, including digital assets, crowdfunding, tokenization, and other innovations in capital markets. email us @CrowdfundInside

Source: DisclosureQuest. Initial Form 1-A only.

Created by Crowded Media Group

This display counts initial Form 1-A filings only. It does not represent subsequent filings, including Form 1-A/A amendments or Form 1-A POS post-qualification updates filed by the issuer. Amounts are the stated Amount to be Raised on the initial filing, not capital raised and not amounts revised in later filings.

0 0 votes
Article Rating
Subscribe
Notify of
guest

This site uses Akismet to reduce spam. Learn how your comment data is processed.

1 Comment
Newest
Oldest Most Voted
 
1
0
Would love your thoughts, please comment.x
()
x
Send this to a friend